SEC Form 4 · accession 0001225208-15-005245
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kieran Gallahue
Director
Period of report
Feb 19, 2015
Accepted (ET)
Feb 23, 2015 · 6:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Acquire)F1 | $133.72 | Feb 19, 2015 | A | 5,376 | A | Feb 19, 2016 | Feb 18, 2022 | Common Stock | 5,376 | 5,376 | D |
Explanation of responses
- F1This option was granted on February 19, 2015 under the Edwards Lifesciences Corporation Nonemployee Directors Stock Incentive Program and becomes exercisable commencing one year after the grant date in three equal annual installments.